{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T23:11:34Z","timestamp":1775085094825,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"1.3.5 project for disciplines of excellence, West China Hospotal, Sichuan University","award":["1.3.5 project for disciplines of excellence"],"award-info":[{"award-number":["1.3.5 project for disciplines of excellence"]}]},{"name":"1.3.5 project for disciplines of excellence, West China Hospotal, Sichuan University","award":["West China Hospotal"],"award-info":[{"award-number":["West China Hospotal"]}]},{"name":"1.3.5 project for disciplines of excellence, West China Hospotal, Sichuan University","award":["Sichuan University"],"award-info":[{"award-number":["Sichuan University"]}]},{"name":"Project of the Health and Family Planning Committee of SichuanProvince, The popularization and promotion of ureteroscopic technique in the treatment of upper urinary tract stones in primary hospitals","award":["16PI294"],"award-info":[{"award-number":["16PI294"]}]},{"name":"Project of Science and Technology Department of Chengdu, Research and application ofurogenital suspension mesh","award":["2016-HM02-00020-SF"],"award-info":[{"award-number":["2016-HM02-00020-SF"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00345-018-2404-6","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:15:00Z","timestamp":1532045700000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms\u2014outcomes from a network meta-analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Zhongyu","family":"Jian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banghua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8289-2791","authenticated-orcid":false,"given":"Kunjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"2404_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S0022-5347(17)63130-6","volume":"97","author":"PD Zimskind","year":"1967","unstructured":"Zimskind PD, Fetter TR, Wilkerson JL (1967) Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 97:840\u2013844","journal-title":"J Urol"},{"key":"2404_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0090-4295(01)01644-2","volume":"59","author":"HB Joshi","year":"2002","unstructured":"Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG (2002) Characterization of urinary symptoms in patients with ureteral stents. Urology 59:511\u2013516","journal-title":"Urology"},{"key":"2404_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/089277901750134421","volume":"15","author":"HB Joshi","year":"2001","unstructured":"Joshi HB, Stainthorpe A, Keeley FX Jr, MacDonagh R, Timoney AG (2001) Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis. J Endourol 15:151\u2013154","journal-title":"J Endourol"},{"key":"2404_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/iju.13311","volume":"24","author":"P Betschart","year":"2017","unstructured":"Betschart P, Zumstein V, Piller A, Schmid HP, Abt D (2017) Prevention and treatment of symptoms associated with indwelling ureteral stents: a systematic review. Int J Urol 24:250\u2013259","journal-title":"Int J Urol"},{"key":"2404_CR5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00345-017-2051-3","volume":"35","author":"J Wang","year":"2017","unstructured":"Wang J, Zhang X, Zhang T, Mu J, Bai B, Lei Y (2017) The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis. World J Urol 35:1669\u20131680","journal-title":"World J Urol"},{"key":"2404_CR6","doi-asserted-by":"publisher","first-page":"f2914","DOI":"10.1136\/bmj.f2914","volume":"346","author":"EJTK Mills","year":"2013","unstructured":"Mills EJTK, Ioannidis JP (2013) Demystifying trial networks and network meta-analysis. BMJ 346:f2914","journal-title":"BMJ"},{"key":"2404_CR7","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700","journal-title":"BMJ"},{"key":"2404_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jclinepi.2005.08.017","volume":"59","author":"N Wiebe","year":"2006","unstructured":"Wiebe N, Vandermeer B, Platt RW, Klassen TP, Moher D, Barrowman NJ (2006) A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol 59:342\u2013353","journal-title":"J Clin Epidemiol"},{"key":"2404_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP (2011) Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64:163\u2013171","journal-title":"J Clin Epidemiol"},{"key":"2404_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.urology.2005.07.038","volume":"67","author":"C Deliveliotis","year":"2006","unstructured":"Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM (2006) Is there a role for alpha 1-blockers in treating double-J stent-related symptoms? Urology 67:35\u201339","journal-title":"Urology"},{"key":"2404_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1089\/end.2007.0257","volume":"22","author":"R Damiano","year":"2008","unstructured":"Damiano R, Autorino R, De Sio M, Giacobbe A, Palumbo IM, D\u2019Armiento M (2008) Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 22:651\u2013656","journal-title":"J Endourol"},{"key":"2404_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.juro.2008.09.026","volume":"181","author":"R Beddingfield","year":"2009","unstructured":"Beddingfield R, Pedro RN, Hinck B, Kreidberg C, Feia K, Monga M (2009) Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 181:170\u2013176","journal-title":"J Urol"},{"key":"2404_CR13","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1089\/end.2009.0173","volume":"23","author":"SC Park","year":"2009","unstructured":"Park SC, Jung SW, Lee JW, Rim JS (2009) The effects of tolterodine extended release and alfuzosin for the treatment of double-J stent-related symptoms. J Endourol 23:1913\u20131917","journal-title":"J Endourol"},{"key":"2404_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00240-009-0182-8","volume":"37","author":"CJ Wang","year":"2009","unstructured":"Wang CJ, Huang SW, Chang CH (2009) Effects of specific \u03b1-1A\/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urol Res 37:147\u2013152","journal-title":"Urol Res"},{"key":"2404_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1089\/end.2012.0036","volume":"26","author":"SM Nazim","year":"2012","unstructured":"Nazim SM, Ather MH (2012) Alpha-blockers impact stent-related symptoms: a randomized, double-blind, placebo-controlled trial. J Endourol 26:1237\u20131241","journal-title":"J Endourol"},{"key":"2404_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00240-013-0554-y","volume":"41","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Huang KH, Yang HJ, Chang HC, Chen J, Yang TK (2013) Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy. Urolithiasis 41:247\u2013252","journal-title":"Urolithiasis"},{"key":"2404_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.urology.2013.08.067","volume":"83","author":"AE Dellis","year":"2014","unstructured":"Dellis AE, Keeley FX, Manolas V, Skolarikos AA (2014) Role of \u03b1-blockers in the treatment of stent-related symptoms: a prospective randomized control study. Urology 83:56\u201361","journal-title":"Urology"},{"key":"2404_CR18","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s11255-014-0825-8","volume":"46","author":"I Singh","year":"2014","unstructured":"Singh I, Tripathy S, Agrawal V (2014) Efficacy of tamsulosin hydrochloride in relieving \u201cdouble-J ureteral stent-related morbidity\u201d: a randomized placebo controlled clinical study. Int Urol Nephrol 46:2279\u20132283","journal-title":"Int Urol Nephrol"},{"key":"2404_CR19","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00345-015-1544-1","volume":"33","author":"J Park","year":"2015","unstructured":"Park J, Yoo C, Han DH, Shin DW (2015) A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2\u2009\u00d7\u20092 factorial randomized trial. World J Urol 33:1833\u20131840","journal-title":"World J Urol"},{"key":"2404_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.aju.2016.01.004","volume":"14","author":"AM Abdelaal","year":"2016","unstructured":"Abdelaal AM, Al-Adl AM, Abdelbaki SA, Al Azab MM, Al Gamal KA (2016) Efficacy and safety of tamsulosin oral-controlled absorption system, solifenacin, and combined therapy for the management of ureteric stent-related symptoms. Arab J Urol 14:115\u2013122","journal-title":"Arab J Urol"},{"key":"2404_CR21","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00345-015-1704-3","volume":"34","author":"AR EL-Nahas","year":"2016","unstructured":"EL-Nahas AR, Tharwat M, Elsaadany M, Mosbah A, Gaballah MA (2016) A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms. World J Urol 34:963\u2013968","journal-title":"World J Urol"},{"key":"2404_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.aju.2016.08.004","volume":"14","author":"IA Hekal","year":"2016","unstructured":"Hekal IA (2016) Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: a contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience. Arab J Urol 14:262\u2013268","journal-title":"Arab J Urol"},{"key":"2404_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12894-016-0186-y","volume":"16","author":"Q Liu","year":"2016","unstructured":"Liu Q, Liao B, Zhang R et al (2016) Combination therapy only shows short-term superiority over monotherapy on ureteral stent-related symptoms\u2013outcome from a randomized controlled trial. BMC Urol 16:66","journal-title":"BMC Urol"},{"key":"2404_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1590\/S1677-5538.IBJU.2015.0186","volume":"42","author":"M Maldonado-Avila","year":"2016","unstructured":"Maldonado-Avila M, Gardu\u00f1o-Arteaga L, Jungfermann-Guzman R et al (2016) Efficacy of tamsulosin, oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms. Int Braz J Urol 42:487\u2013493","journal-title":"Int Braz J Urol"},{"key":"2404_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1590\/S1677-5538.IBJU.2015.0570","volume":"42","author":"L Zhang","year":"2016","unstructured":"Zhang L, Li J, Pan M, Han W, Liu S, Xiao Y (2016) Doxazosin oral intake therapy to relieve stent-related urinary symptoms and pain: a prospective, randomized, controlled study. Int Braz J Urol 42:727\u2013733","journal-title":"Int Braz J Urol"},{"key":"2404_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00345-016-1988-y","volume":"35","author":"MH Abdelhamid","year":"2017","unstructured":"Abdelhamid MH, Zayed AS, Ghoneima WE et al (2017) Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospium chloride in the relief of double-J stent-related symptoms. World J Urol 35:1261\u20131268","journal-title":"World J Urol"},{"key":"2404_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1089\/end.2016.0663","volume":"31","author":"AE Dellis","year":"2017","unstructured":"Dellis AE, Papatsoris AG, Keeley FX Jr et al (2017) Tamsulosin, solifenacin, and their combination for the treatment of stent-related symptoms: a randomized controlled study. J Endourol 31:100\u2013109","journal-title":"J Endourol"},{"key":"2404_CR28","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s11255-017-1561-7","volume":"49","author":"M Ragab","year":"2017","unstructured":"Ragab M, Soliman MG, Tawfik A et al (2017) The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial. Int Urol Nephrol 49:961\u2013966","journal-title":"Int Urol Nephrol"},{"key":"2404_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00345-016-1958-4","volume":"35","author":"Y Tanidir","year":"2016","unstructured":"Tanidir Y, Mangir N, Sahan A, Ulukaya M (2016) Turkish version of the ureteral stent symptoms questionnaire: linguistic and psychometric validation. World J Urol 35:1149\u20131154","journal-title":"World J Urol"},{"key":"2404_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/1536867X0900900103","volume":"9","author":"I White","year":"2009","unstructured":"White I (2009) Multivariate random-effects meta-analysis. Stata J 9:40\u201356","journal-title":"Stata J"},{"key":"2404_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrurol.2014.340","volume":"12","author":"D Lange","year":"2015","unstructured":"Lange D, Bidnur S, Hoag N, Chew BH (2015) Ureteral stent-associated complications\u2014where we are and where we are going. Nat Rev Urol 12:17\u201325","journal-title":"Nat Rev Urol"},{"key":"2404_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/iju.12008","volume":"20","author":"O Yamaguchi","year":"2013","unstructured":"Yamaguchi O (2013) Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action. Int J Urol 20:28\u201339","journal-title":"Int J Urol"},{"key":"2404_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000323855","volume":"87","author":"G Mokhtari","year":"2011","unstructured":"Mokhtari G, Shakiba M, Ghodsi S et al (2011) Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial. Urol Int 87:19\u201322","journal-title":"Urol Int"},{"key":"2404_CR34","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1590\/S1677-5538.IBJU.2013.06.09","volume":"39","author":"A Tehranchi","year":"2013","unstructured":"Tehranchi A, Rezaei Y, Khalkhali H, Rezaei M (2013) Effects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trial. Int Braz J Urol 39:832\u2013840","journal-title":"Int Braz J Urol"},{"key":"2404_CR35","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.5489\/cuaj.145","volume":"6","author":"U Kuyumcuoglu","year":"2012","unstructured":"Kuyumcuoglu U, Eryildirim B, Tuncer M, Tarhan F, Ozg\u00fcl A (2012) Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Can Urol Assoc J 6:E234\u2013E237","journal-title":"Can Urol Assoc J"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2404-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2404-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2404-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T17:29:56Z","timestamp":1566926996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2404-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2404"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2404-6","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this article as well as all the included studies declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol is compliant with ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}